Neolife SA (ALNLF) - Net Assets
Based on the latest financial reports, Neolife SA (ALNLF) has net assets worth €4.94 Million EUR (≈ $5.77 Million USD) as of December 2024. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (€8.85 Million ≈ $10.34 Million USD) and total liabilities (€3.91 Million ≈ $4.57 Million USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check ALNLF financial resilience to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | €4.94 Million |
| % of Total Assets | 55.79% |
| Annual Growth Rate | 70.65% |
| 5-Year Change | 130.99% |
| 10-Year Change | 79.85% |
| Growth Volatility | 36841.37 |
Neolife SA - Net Assets Trend (2013–2024)
This chart illustrates how Neolife SA's net assets have evolved over time, based on quarterly financial data. Also explore Neolife SA assets under control for the complete picture of this company's asset base.
Annual Net Assets for Neolife SA (2013–2024)
The table below shows the annual net assets of Neolife SA from 2013 to 2024. For live valuation and market cap data, see how much is Neolife SA worth.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | €4.94 Million ≈ $5.77 Million |
+14.77% |
| 2023-12-31 | €4.30 Million ≈ $5.03 Million |
-10.85% |
| 2022-12-31 | €4.82 Million ≈ $5.64 Million |
+18.13% |
| 2021-12-31 | €4.08 Million ≈ $4.77 Million |
+91.10% |
| 2020-12-31 | €2.14 Million ≈ $2.50 Million |
-13.50% |
| 2019-12-31 | €2.47 Million ≈ $2.89 Million |
+128806.78% |
| 2018-12-31 | €1.92K ≈ $2.24K |
+5.92% |
| 2017-12-31 | €1.81K ≈ $2.12K |
+42.46% |
| 2016-12-31 | €1.27K ≈ $1.48K |
-99.95% |
| 2015-12-31 | €2.74 Million ≈ $3.21 Million |
+66.59% |
| 2014-12-31 | €1.65 Million ≈ $1.93 Million |
+11835.83% |
| 2013-12-31 | €13.80K ≈ $16.14K |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Neolife SA's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 130913600.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | €472.94K | 9.58% |
| Common Stock | €4.83 Million | 97.81% |
| Total Equity | €4.94 Million | 100.00% |
Neolife SA Competitors by Market Cap
The table below lists competitors of Neolife SA ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Tourn International AB
ST:TOURN
|
$4.73 Million |
|
Qualigen Therapeutics Inc
NASDAQ:QLGN
|
$4.74 Million |
|
Helios Energy Ltd
AU:HE8
|
$4.74 Million |
|
Sentral Mitra Informatika Tbk PT
JK:LUCK
|
$4.74 Million |
|
IDeA Indonesia Akademi Tbk PT
JK:IDEA
|
$4.73 Million |
|
Vectus Biosystems Ltd
AU:VBS
|
$4.73 Million |
|
DEFSEC Technologies Inc.
NASDAQ:DFSC
|
$4.72 Million |
|
Cluey Ltd
AU:CLU
|
$4.72 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Neolife SA's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from 4,300,820 to 4,936,258, a change of 635,438 (14.8%).
- Net income of 473,000 contributed positively to equity growth.
- Other comprehensive income increased equity by 1.
- Other factors increased equity by 162,437.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | €473.00K | +9.58% |
| Other Comprehensive Income | €1.00 | +0.0% |
| Other Changes | €162.44K | +3.29% |
| Total Change | €- | 14.77% |
Book Value vs Market Value Analysis
This analysis compares Neolife SA's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.82x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 32.09x to 0.82x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2013-12-31 | €0.00 | €0.04 | x |
| 2014-12-31 | €0.13 | €0.04 | x |
| 2015-12-31 | €0.25 | €0.04 | x |
| 2016-12-31 | €0.08 | €0.04 | x |
| 2017-12-31 | €0.08 | €0.04 | x |
| 2018-12-31 | €0.07 | €0.04 | x |
| 2019-12-31 | €0.05 | €0.04 | x |
| 2020-12-31 | €0.04 | €0.04 | x |
| 2021-12-31 | €0.04 | €0.04 | x |
| 2022-12-31 | €0.05 | €0.04 | x |
| 2023-12-31 | €0.04 | €0.04 | x |
| 2024-12-31 | €0.05 | €0.04 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Neolife SA utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 9.58%
- The company has moderate efficiency in generating returns from equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 3.89%
- • Asset Turnover: 1.38x
- • Equity Multiplier: 1.79x
- Recent ROE (9.58%) is above the historical average (-419.87%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2013 | -4276.29% | -57.80% | 0.52x | 142.03x | €-591.64K |
| 2014 | -87.91% | -85.04% | 0.36x | 2.84x | €-1.61 Million |
| 2015 | -59.31% | -41.57% | 0.58x | 2.47x | €-1.85 Million |
| 2016 | -246.87% | -66.96% | 0.94x | 3.91x | €-3.26K |
| 2017 | -117.83% | -29.64% | 1.23x | 3.23x | €-2.30K |
| 2018 | -97.00% | -25.83% | 1.47x | 2.55x | €-2.05K |
| 2019 | -37.67% | -11.19% | 1.59x | 2.11x | €-1.18 Million |
| 2020 | -24.16% | -6.59% | 1.10x | 3.32x | €-729.98K |
| 2021 | -13.64% | -2.83% | 1.28x | 3.75x | €-526.88K |
| 2022 | -75.14% | -27.21% | 1.60x | 1.73x | €-4.11 Million |
| 2023 | -12.17% | -3.90% | 1.83x | 1.71x | €-953.61K |
| 2024 | 9.58% | 3.89% | 1.38x | 1.79x | €-20.63K |
Industry Comparison
This section compares Neolife SA's net assets metrics with peer companies in the Furnishings, Fixtures & Appliances industry.
Industry Context
- Industry: Furnishings, Fixtures & Appliances
- Average net assets among peers: $169,256,334
- Average return on equity (ROE) among peers: 119.31%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Neolife SA (ALNLF) | €4.94 Million | -4276.29% | 0.79x | $4.73 Million |
| Groupe Airwell Société anonyme (ALAIR) | $262.00K | 761.12% | 89.73x | $3.89 Million |
| Miliboo SA (ALMLB) | $4.76 Million | -28.05% | 1.30x | $12.20 Million |
| U10 SA (ALU10) | $42.75 Million | 6.53% | 2.13x | $19.80 Million |
| Foncière 7 investissement Société Anonyme (LEBL) | $574.00K | -70.38% | 0.18x | $480.00K |
| Roche Bobois (RBO) | $104.79 Million | 29.88% | 3.30x | $263.43 Million |
| SEB SA (SK) | $862.40 Million | 16.76% | 1.83x | $2.85 Billion |
About Neolife SA
Neolife SA manufactures and sells construction materials. The company offers cladding panels, decorative profiles, molding, and decking boards. It also provides BimObject for designing and modelling BIM projects. The company was incorporated in 2012 and is based in Champagne-Au-Mont-D'Or, France.